|
MRPS30 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78446146748001E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.97966121063109E-13 |
| Normal-vs-Stage2 |
2.572100E-04 |
| Normal-vs-Stage3 |
5.06106268005624E-12 |
| Normal-vs-Stage4 |
5.98370020199468E-10 |
| Stage1-vs-Stage2 |
5.393700E-02 |
| Stage1-vs-Stage3 |
5.697000E-01 |
| Stage1-vs-Stage4 |
9.082800E-01 |
| Stage2-vs-Stage3 |
3.846100E-02 |
| Stage2-vs-Stage4 |
1.431160E-01 |
| Stage3-vs-Stage4 |
6.110400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48689957516035E-14 |
| Normal-vs-AfricanAmerican |
1.5507999995279E-07 |
| Normal-vs-Asian |
3.58310048298449E-10 |
| Caucasian-vs-AfricanAmerican |
9.542800E-01 |
| Caucasian-vs-Asian |
8.688600E-01 |
| AfricanAmerican-vs-Asian |
8.576200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.23959731368473E-11 |
| Normal-vs-Female |
2.73414624274437E-12 |
| Male-vs-Female |
9.640800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.49739998178688E-10 |
| Normal-vs-Age(41-60Yrs) |
2.68673971959288E-14 |
| Normal-vs-Age(61-80Yrs) |
1.05330000277348E-08 |
| Normal-vs-Age(81-100Yrs) |
1.363050E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.761800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.923000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.019600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.268760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.175200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.342200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.183200E-01 |
| Classical-VS-Follicular |
9.592200E-01 |
| Classical-VS-Other |
6.696400E-01 |
| Classical-VS-Normal |
2.09632311509722E-12 |
| Tall-VS-Follicular |
5.290800E-01 |
| Tall-VS-Other |
9.153600E-01 |
| Tall-VS-Normal |
1.55189999739846E-08 |
| Follicular-VS-Other |
7.386000E-01 |
| Follicular-VS-Normal |
3.27239999542428E-08 |
| Other-VS-Normal |
7.838400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67927910360777E-13 |
| Normal-vs-N1 |
7.23059999652165E-08 |
| N0-vs-N1 |
5.160400E-01 |
|
|
